: EU regulator starts ‘rolling review’ of China’s Sinovac COVID-19 vaccine


The European Medicines Agency has started a rolling review of China’s Sinovac COVID-19 vaccine to assess its effectiveness and safety, the first step toward possible authorization of the shot in the 27-member bloc.

London Markets: FTSE 100 outpaces European indexes, lifted by airlines, commodity stocks and manufacturing data

Previous article

BookWatch: Here’s why local hospitals, not insurance companies, are to blame for exploding healthcare costs

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News